Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

(2015) Anne-Katrin Pröbstel et al.   Journal of Neuroinflammation

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

(2015) Dean M. Wingerchuk et al.   NEUROLOGY

Evidence for classic complement activity in neuromyelitis optica

(2014) Melina V. Jones et al.   CLINICAL NEUROPATHOLOGY

Longitudinally extensive NMO spinal cord pathology produced by passive transfer of NMO-IgG in mice lacking complement inhibitor CD59

(2014) Hua Zhang et al.   JOURNAL OF AUTOIMMUNITY

Complement activation in patients with neuromyelitis optica

(2014) Petra Nytrova et al.   JOURNAL OF NEUROIMMUNOLOGY

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

(2014) Marios C. Papadopoulos et al.   Nature Reviews Neurology

Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain

(2014) Samira Saadoun et al.   Acta Neuropathologica Communications

Clinical Spectrum and Treatment of Neuromyelitis Optica Spectrum Disorders: Evolution and Current Status

(2013) Douglas Kazutoshi Sato et al.   BRAIN PATHOLOGY

Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature

(2013) Sven Jarius et al.   BRAIN PATHOLOGY

Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study

(2013) Sean J Pittock et al.   LANCET NEUROLOGY

A systematic analysis of the complement pathways in patients with neuromyelitis optica indicates alteration but no activation during remission

(2013) Nóra Veszeli et al.   MOLECULAR IMMUNOLOGY

Anti-Aquaporin-1 Autoantibodies in Patients with Neuromyelitis Optica Spectrum Disorders

(2013) John S. Tzartos et al.   PLoS One

Increased Soluble C5b-9 in CSF of Neuromyelitis Optica

(2013) H. Wang et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Longitudinally Extensive Transverse Myelitis With and Without Aquaporin 4 Antibodies

(2013) Joanna Kitley et al.   JAMA Neurology

Applications of ROC Analysis in Medical Research

(2012) Demissie Alemayehu et al.   ACADEMIC RADIOLOGY

Failure of Natalizumab to Prevent Relapses in Neuromyelitis Optica

(2012) Ingo Kleiter   ARCHIVES OF NEUROLOGY

Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan

(2012) Joanna Kitley et al.   BRAIN

Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica

(2012) Hiroshi Kuroda et al.   JOURNAL OF NEUROIMMUNOLOGY

Aquaporin 4 and neuromyelitis optica

(2012) Marios C Papadopoulos et al.   LANCET NEUROLOGY

Systemic complement profiling in multiple sclerosis as a biomarker of disease state

(2012) G Ingram et al.   Multiple Sclerosis Journal

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Enhanced complement consumption in neuromyelitis optica and Behçet's disease patients

(2011) Erdem Tüzün et al.   JOURNAL OF NEUROIMMUNOLOGY

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders

(2011) Simone Mader et al.   Journal of Neuroinflammation

Interferon Beta Treatment in Neuromyelitis Optica

(2010) Jacqueline Palace et al.   ARCHIVES OF NEUROLOGY

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice

(2010) Samira Saadoun et al.   BRAIN

Elevated plasma C4a levels in multiple sclerosis correlate with disease activity

(2010) Gillian Ingram et al.   JOURNAL OF NEUROIMMUNOLOGY

AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance

(2010) Sven Jarius et al.   Nature Reviews Neurology

IFN -1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum

(2010) J. Shimizu et al.   NEUROLOGY